全文获取类型
收费全文 | 3043篇 |
免费 | 249篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 69篇 |
妇产科学 | 137篇 |
基础医学 | 510篇 |
口腔科学 | 44篇 |
临床医学 | 375篇 |
内科学 | 636篇 |
皮肤病学 | 110篇 |
神经病学 | 249篇 |
特种医学 | 93篇 |
外科学 | 272篇 |
综合类 | 66篇 |
预防医学 | 154篇 |
眼科学 | 73篇 |
药学 | 234篇 |
中国医学 | 15篇 |
肿瘤学 | 231篇 |
出版年
2023年 | 19篇 |
2022年 | 32篇 |
2021年 | 87篇 |
2020年 | 57篇 |
2019年 | 82篇 |
2018年 | 94篇 |
2017年 | 87篇 |
2016年 | 77篇 |
2015年 | 116篇 |
2014年 | 143篇 |
2013年 | 183篇 |
2012年 | 238篇 |
2011年 | 254篇 |
2010年 | 170篇 |
2009年 | 142篇 |
2008年 | 219篇 |
2007年 | 193篇 |
2006年 | 170篇 |
2005年 | 151篇 |
2004年 | 129篇 |
2003年 | 112篇 |
2002年 | 93篇 |
2001年 | 72篇 |
2000年 | 41篇 |
1999年 | 63篇 |
1998年 | 28篇 |
1997年 | 19篇 |
1996年 | 12篇 |
1995年 | 6篇 |
1994年 | 14篇 |
1993年 | 6篇 |
1992年 | 12篇 |
1991年 | 21篇 |
1990年 | 20篇 |
1989年 | 15篇 |
1988年 | 27篇 |
1987年 | 16篇 |
1986年 | 16篇 |
1985年 | 10篇 |
1984年 | 16篇 |
1983年 | 4篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 8篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1975年 | 3篇 |
1974年 | 5篇 |
1971年 | 4篇 |
1969年 | 2篇 |
排序方式: 共有3316条查询结果,搜索用时 15 毫秒
71.
72.
73.
Michael E. Birnbaum Richard Berry Yu-Shan Hsiao Zhenjun Chen Miguel A. Shingu-Vazquez Xiaoling Yu Deepa Waghray Suzanne Fischer James McCluskey Jamie Rossjohn Thomas Walz K. Christopher Garcia 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(49):17576-17581
αβ T-cell receptor (TCR) activation plays a crucial role for T-cell function. However, the TCR itself does not possess signaling domains. Instead, the TCR is noncovalently coupled to a conserved multisubunit signaling apparatus, the CD3 complex, that comprises the CD3εγ, CD3εδ, and CD3ζζ dimers. How antigen ligation by the TCR triggers CD3 activation and what structural role the CD3 extracellular domains (ECDs) play in the assembled TCR–CD3 complex remain unclear. Here, we use two complementary structural approaches to gain insight into the overall organization of the TCR–CD3 complex. Small-angle X-ray scattering of the soluble TCR–CD3εδ complex reveals the CD3εδ ECDs to sit underneath the TCR α-chain. The observed arrangement is consistent with EM images of the entire TCR–CD3 integral membrane complex, in which the CD3εδ and CD3εγ subunits were situated underneath the TCR α-chain and TCR β-chain, respectively. Interestingly, the TCR–CD3 transmembrane complex bound to peptide–MHC is a dimer in which two TCRs project outward from a central core composed of the CD3 ECDs and the TCR and CD3 transmembrane domains. This arrangement suggests a potential ligand-dependent dimerization mechanism for TCR signaling. Collectively, our data advance our understanding of the molecular organization of the TCR–CD3 complex, and provides a conceptual framework for the TCR activation mechanism.T cells are key mediators of the adaptive immune response. Each αβ T cell contains a unique αβ T-cell receptor (TCR), which binds antigens (Ags) displayed by major histocompatibility complexes (MHCs) and MHC-like molecules (1). The TCR serves as a remarkably sensitive driver of cellular function: although TCR ligands typically bind quite weakly (1–200 μM), even a handful of TCR ligands are sufficient to fully activate a T cell (2, 3). The TCR does not possess intracellular signaling domains, uncoupling Ag recognition from T-cell signaling. The TCR is instead noncovalently associated with a multisubunit signaling apparatus, consisting of the CD3εγ and CD3εδ heterodimers and the CD3ζζ homodimer, which collectively form the TCR–CD3 complex (4, 5). The CD3γ/δ/ε subunits each consist of a single extracellular Ig domain and a single immunoreceptor tyrosine-based activation motif (ITAM), whereas CD3ζ has a short extracellular domain (ECD) and three ITAMs (6–11). The TCR–CD3 complex exists in 1:1:1:1 stoichiometry for the αβTCR:CD3εγ:CD3εδ:CD3ζζ dimers (12). Phosphorylation of the intracellular CD3 ITAMs and recruitment of the adaptor Nck lead to T-cell activation, proliferation, and survival (13, 14). Understanding the underlying principles of TCR–CD3 architecture and T-cell signaling is of therapeutic interest. For example, TCR–CD3 is the target of therapeutic antibodies such as the immunosuppressant OKT3 (15), and there is increasing interest in manipulating T cells in an Ag-dependent manner by using naturally occurring and engineered TCRs (16).Assembly of the TCR–CD3 complex is primarily driven by each protein’s transmembrane (TM) region, enforced through the interaction of evolutionarily conserved, charged, residues in each TM region (4, 5, 12). What, if any, role interactions between TCR and CD3 ECDs play in the assembly and function of the complex remains controversial (5): there are several plausible proposed models of activation, which are not necessarily mutually exclusive (5, 17–19). Although structures of TCR–peptide–MHC (pMHC) complexes (2), TCR–MHC-I–like complexes (1), and the CD3 dimers (6–10) have been separately determined, how the αβ TCR associates with the CD3 complex is largely unknown. Here, we use two independent structural approaches to gain an understanding of the TCR–CD3 complex organization and structure. 相似文献
74.
75.
ChiaPin Lin YingChang Tung FuChih Hsiao ChiaHung Yang YiWei Kao YuSheng Lin YouChia Chu PaoHsien Chu 《Journal of clinical hypertension (Greenwich, Conn.)》2020,22(10):1846
Hypertension and dyslipidemia are important risk factors for cardiovascular disease. However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent combination (FEC) of amlodipine and atorvastatin in the treatment of concurrent hypertension and dyslipidemia remain unknown. In this study, we included patients with newly diagnosed hypertension and dyslipidemia, without previously established cardiovascular disease, and treated with either FDC or FEC of amlodipine and atorvastatin were identified from the National Health Insurance Research Database of Taiwan and follow‐up for 5 years. By using 1:1 propensity score matching, a total of 1756 patients were enrolled in this study. The composite of major adverse cardiovascular events, including all‐cause mortality, myocardial infarction (MI), stroke, and coronary revascularization, occurred more frequently in the FEC group than in the FDC group (hazard ratio, 1.88; 95% confidence interval [CI], 1.42 to 2.5). Although the all‐cause mortality did not differ (hazard ratio, 0.46; 95% CI, 0.36 to 1.59), the FEC group developed increased MI, stroke, and coronary revascularization (hazard ratio, 2.87; 95% CI, 1.07 to 7.68; hazard ratio, 1.97; 95% CI, 1.41 to 2.74; and hazard ratio, 2.44; 95% CI, 1.26 to 4.69, respectively). Furthermore, as an unexpected result, a higher risk to develop new‐onset diabetes mellitus was observed with FEC regimens (hazard ratio, 2.19; 95% CI, 1.6 to 3.0). In conclusion, although the all‐cause mortality did not differ between the two groups, the FDC regimen of amlodipine and atorvastatin improved clinical outcomes when compared to FEC in patients with newly diagnosed hypertension and dyslipidemia. 相似文献
76.
77.
Heng-Jung Hsu Chiung-Hui Yen Chih-Ken Chen Kuang-Hung Hsu Cheng-Cheng Hsiao Chin-Chan Lee I-Wen Wu Chiao-Yin Sun Chia-Chi Chou Ming-Fang Hsieh Chun-Yu Chen Chiao-Ying Hsu Chi-Jen Tsai Mai-Szu Wu 《Experimental gerontology》2012
Objective
The incidence of chronic kidney disease (CKD) is on the rise. CKD patients are at high risk of cardiovascular (CVD) and all-cause mortality. CKD patients have several endocrine disorders, including low levels of dehydroepiandrosterone sulfate (DHEA-S). In the general population, low levels of DHEA-S are associated with high CVD and all-cause mortality. The aim of this study was to analyze the prognostic value of plasma DHEA-S on the survival of CKD patients on hemodialysis.Method
This was a single-center prospective cohort study on two hundred CKD patients on hemodialysis, which assessed the prognostic value of plasma DHEA-S on their survival.Result
We found that plasma DHEA-S levels were negatively associated with age, and positively associated with dialysis duration and plasma creatinine, albumin, and phosphate levels in hemodialysis men. Elderly patients with co-morbidities (i.e. diabetes mellitus, congestive heart failure, and chronic obstructive pulmonary disease), poorer fluid control which was evaluated by higher cardiothoracic ratio, and low plasma creatinine and albumin levels seemed to have poor prognosis in hemodialysis men. Furthermore, low plasma DHEA-S levels were significantly associated with CVD-related [hazard ratio (HR) = 3.877; P = 0.021], non-CVD-related (HR = 3.522; P = 0.016), and all-cause mortality (HR = 3.667; P = 0.001) in hemodialysis men. But low plasma DHEA-S levels were not significantly associated with CVD-related, non-CVD-related, and all-cause mortality in hemodialysis women. Multivariate Cox regression analysis suggested that low plasma DHEA-S levels are significantly and independently associated with all-cause mortality in hemodialysis men (HR = 2.933; P = 0.033).Conclusion
The study suggested that low plasma DHEA-S was independently and significantly associated with all-cause mortality in CKD hemodialysis men. 相似文献78.
79.
Zhang XJ Leung FP Hsiao WW Tan S Li S Xu HX Sung JJ Bian ZX 《World journal of gastroenterology : WJG》2012,18(23):2914-2928
AIM: To investigate proteomic changes in spinal cord and dorsal root ganglia (DRG) of rats with trinitrobenzene sulfonic acid (TNBS)-induced colitis.METHODS: The colonic myeloperoxidase (MPO) activity and tumor necrosis factor-α (TNF-α) level were determined. A two-dimensional electrophoresis (2-DE)-based proteomic technique was used to profile the global protein expression changes in the DRG and spinal cord of the rats with acute colitis induced by intra-colonic injection of TNBS.RESULTS: TNBS group showed significantly elevated colonic MPO activity and increased TNF-α level. The proteins derived from lumbosacral enlargement of the spinal cord and DRG were resolved by 2-DE; and 26 and 19 proteins that displayed significantly different expression levels in the DRG and spinal cord were identified respectively. Altered proteins were found to be involved in a number of biological functions, such as inflammation/immunity, cell signaling, redox regulation, sulfate transport and cellular metabolism. The overexpression of the protein similar to potassium channel tetramerisation domain containing protein 12 (Kctd 12) and low expression of proteasome subunit α type-1 (psma) were validated by Western blotting analysis.CONCLUSION: TNBS-induced colitis has a profound impact on protein profiling in the nervous system. This result helps understand the neurological pathogenesis of inflammatory bowel disease. 相似文献
80.
Jia-Huei Hsiao Shih-Wen Chen Bing-Yi Hung Kasimayan Uma Wei-Cheng Chen Chi-Ching Kuo Ja-Hon Lin 《RSC advances》2020,10(13):7551
The resonant energy transfer enhancement from a plasmonic random laser (PRL) has been investigated by means of a dye-covered PVA film with embedded silver nanoplates (DC-PVA/AgNPs). Different sizes and morphologies of AgNPs were adopted to shift the localized surface plasmon resonance (LSPR) and intensify recurrent light scattering between the AgNPs. For better overlap between surface plasmon resonance and the photoluminescence of fluorescent molecules with appropriately-sized silver nanoprisms, the slope efficiency of the PRL was greatly enhanced and the lasing threshold was obviously reduced. In addition, the photon lifetime for the DC-PVA/AgNPs film reveals an apparent decline around 1.39 ns owing to better coupling with LSPR. The stronger light scattering of samples with bigger-sized silver nanoprisms has been demonstrated by coherent back scattering measurements, which reveals a smaller transport mean free path around 3.3 μm. With α-stable analysis, it has been successfully demonstrated that the tail exponent α can be regarded as an identifier of the threshold of random lasing.The resonant energy transfer enhancement from a plasmonic random laser has been investigated by means of a dye-covered PVA film embedded with silver nanoplates with different sizes and morphologies. 相似文献